This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kizer, L.
Right arrow Articles by Keasling, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kizer, L.
Right arrow Articles by Keasling, J. D.
Agricola
Right arrow Articles by Kizer, L.
Right arrow Articles by Keasling, J. D.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, May 2008, p. 3229-3241, Vol. 74, No. 10
0099-2240/08/$08.00+0     doi:10.1128/AEM.02750-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Application of Functional Genomics to Pathway Optimization for Increased Isoprenoid Production{triangledown}

Lance Kizer,1 Douglas J. Pitera,1 Brian F. Pfleger,1 and Jay D. Keasling1,2,3*

Department of Chemical Engineering, University of California, Berkeley, California 94720-1462,1 Department of Bioengineering, University of California, Berkeley, California 94720-1762,2 Synthetic Biology Department, Physical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 947203

Received 6 December 2007/ Accepted 4 March 2008

Producing complex chemicals using synthetic metabolic pathways in microbial hosts can have many advantages over chemical synthesis but is often complicated by deleterious interactions between pathway intermediates and the host cell metabolism. With the maturation of functional genomic analysis, it is now technically feasible to identify modes of toxicity associated with the accumulation of foreign molecules in the engineered bacterium. Previously, Escherichia coli was engineered to produce large quantities of isoprenoids by creating a mevalonate-based isopentenyl pyrophosphate biosynthetic pathway (V. J. J. Martin et al., Nat. Biotechnol. 21:796-802, 2003). The engineered E. coli strain produced high levels of isoprenoids, but further optimization led to an imbalance in carbon flux and the accumulation of the pathway intermediate 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA), which proved to be cytotoxic to E. coli. Using both DNA microarray analysis and targeted metabolite profiling, we have studied E. coli strains inhibited by the intracellular accumulation of HMG-CoA. Our results indicate that HMG-CoA inhibits fatty acid biosynthesis in the microbial host, leading to generalized membrane stress. The cytotoxic effects of HMG-CoA accumulation can be counteracted by the addition of palmitic acid (16:0) and, to a lesser extent, oleic acid (cis-{Delta}9-18:1) in the growth medium. This work demonstrates the utility of using transcriptomic and metabolomic methods to optimize synthetic biological systems.


* Corresponding author. Mailing address: Berkeley Center for Synthetic Biology, University of California, 717 Potter Street, Building 977, Mail Code 3224, Berkeley, CA 94720-3224. Phone: (510) 642-4862. Fax: (510) 495-2630. E-mail: keasling{at}berkeley.edu

{triangledown} Published ahead of print on 14 March 2008.


Applied and Environmental Microbiology, May 2008, p. 3229-3241, Vol. 74, No. 10
0099-2240/08/$08.00+0     doi:10.1128/AEM.02750-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Kennedy, C. J., Boyle, P. M., Waks, Z., Silver, P. A. (2009). Systems-Level Engineering of Nonfermentative Metabolism in Yeast. Genetics 183: 385-397 [Abstract] [Full Text]